Exclusive

Publication

Byline

Clinical Trial: Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159217) titled 'Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced B... Read More


Clinical Trial: A Risk Score for Prediction of Gestational Diabetesmellitus in China Using Routinely Collected Hospital Data

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160920) titled 'A Risk Score for Prediction of Gestational Diabetesmellitus in China Using Routinely Collec... Read More


Clinical Trial: Study of Protection And Repair of Endothelial-glycocalyx in Sepsis

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160426) titled 'Study of Protection And Repair of Endothelial-glycocalyx in Sepsis' on Aug. 29. Brief Summ... Read More


Clinical Trial: A Study of Cizutamig in Systemic Sclerosis

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07158996) titled 'A Study of Cizutamig in Systemic Sclerosis' on Aug. 25. Brief Summary: The purpose of this... Read More


Clinical Trial: A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159451) titled 'A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Com... Read More


Clinical Trial: Cannabis Abstinence and Neurocognitive Assessment in Adolescence

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160153) titled 'Cannabis Abstinence and Neurocognitive Assessment in Adolescence' on Aug. 27. Brief Summar... Read More


Clinical Trial: Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159906) titled 'Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffus... Read More


Clinical Trial: A Preliminary Evaluation of Digital Behavioral Interventions

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160439) titled 'A Preliminary Evaluation of Digital Behavioral Interventions' on Aug. 29. Brief Summary: D... Read More


Clinical Trial: Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160205) titled 'Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With D... Read More


Clinical Trial: Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159360) titled 'Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents Wit... Read More